ObjectiveThe main aim of the current study was to investigate whether SKA2 gene expression in the postmortem brain of rs7208505 genotype are altered in suicide victims from a Mexican population.MethodsIn this study, we report a genetic analysis of expression levels of the SKA2 gene in the prefrontal cortex of the postmortem brain of suicidal subjects (n = 22) compared to subjects who died of causes other than suicide (n = 22) in a Mexican population using RT-qPCR assays. Additionally, we genotyped the rs7208505 polymorphism in suicide victims (n = 98) and controls (n = 88) and we evaluate the association of genotypes for the SNP rs7208505 with expression level of SKA2.ResultsThe results showed that the expression of the SKA2 gene was significantly higher in suicide victims compared to control subjects (p = 0.044). Interestingly, we observed a greater proportion of allele A of the rs7208505 in suicide victims than controls. Even though there was no association between the SNP with suicide in the study population we found a significative association of the expression level from SKA2 with the allele A of the rs7208505 and suicide.ConclusionThe evidence suggests that the expression of SKA2 in the prefrontal cortex may be a critical factor in the etiology of suicidal behavior.

Suicide is a complex phenomenon and a global public health problem that involves several biological factors that could contribute to the pathophysiology of suicide. There is evidence that epigenetic factors influence some psychiatric disorders, suggesting a predisposition to suicide or suicidal behavior. Here, we review studies of molecular mechanisms of suicide in an epigenetic perspective in the postmortem brain of suicide completers and peripheral blood cells of suicide attempters. Besides, we include studies of gene-specific DNA methylation, epigenome-wide association, histone modification, and interfering RNAs as epigenetic factors. This review provides an overview of the epigenetic mechanisms described in different biological systems related to suicide, contributing to an understanding of the genetic regulation in suicide. We conclude that epigenetic marks are potential biomarkers in suicide, and they could become attractive therapeutic targets due to their reversibility and importance in regulating gene expression.

Background: Schizophrenia (SCZ) is a severe mental illness that affects one percent of the population, affecting how people think, feel, and behave. Evidence suggests glial cell alteration and some researchers have found genetic risk loci and epigenetic marks that may regulate glia-related genes implicated in SCZ. Aim: The aim of this study is to identify genetic and epigenetic changes that have been reported in glial cells or glial-associated genes in SCZ. Materials and Methods: We searched the articles from PubMed, PubMed Central, Medline, Medscape, and Embase databases up to December 2020 to identify relevant peer-reviewed articles in English. The titles and abstracts were screened to eliminate irrelevant citations. Results: Twenty-four original articles were included in the review. Studies were categorized into the following four thematic via: (1) oligodendrocytes, (2) microglia, (3) astrocytes, and (4) perspectives. Conclusion: This study is the first of its kind to review research on genetic variants and epigenetic modifications associated with glia-related genes implicated in SCZ. Epigenetic evidence is considerably less than genetic evidence in this field. Understanding the pathways of some risk genes and their genetic and epigenetic regulation allows us to understand and find potential targets for future interventions in this mental illness.

The growing demand for lithium, driven by its key role in rechargeable batteries and its use in electric vehicles, highlights the need for sustainable and environmentally friendly recovery strategies. Conventional methods, such as pyrometallurgy and hydrometallurgy, are effective but costly and harmful as they emit toxic compounds. Biohydrometallurgy has emerged as a promising alternative, as it uses microorganisms and their metabolites to solubilize metals under milder conditions. Biohydrometallurgy has emerged as a promising alternative, as it relies on microorganisms and their metabolites to solubilize metals under mild operating conditions. Nevertheless, challenges related to process efficiency and selectivity remain, particularly for lithium recovery. In this context, recent advances in metal-binding peptides have attracted increasing attention due to their inherent selectivity and the possibility of rational design and heterologous expression in well-established microbial hosts such as Escherichia coli, Bacillus subtilis, and Saccharomyces cerevisiae. This review critically analyzes current biotechnological strategies and explores the integration of microbial bioleaching with peptide-based approaches as a complementary and environmentally friendly framework for the selective recovery of lithium and other metals from spent batteries and waste electrical and electronic equipment. Overall, this review provides an integrative conceptual framework that highlights the potential of combining microbial processes with metal-binding peptides to guide the development of more selective and sustainable biotechnological strategies for lithium recovery from secondary sources.